Phase <scp>II</scp> study of bortezomib, cyclophosphamide and dexamethasone as induction therapy in multiple myeloma: <scp>DSMM XI</scp> trial

Hermann Einsele, Stefan Knop, Christoph Tapprich et al.|British Journal of Haematology|2017

Cited by 30